Pretreatment with dexmedetomidine: Altered indices of anesthetic depth for halothane in the neuraxis of cats

Anesthesia and Analgesia

Volumn 88, Issue 3, 1999, Pages 625-632

  Schmeling, William T ^a   Ganjoo, Pragati ^a   Staunton, Michael ^b   Drexler, Cathy ^c   Farber, Neu E ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital of Wisconsin   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; HALOTHANE;

ANESTHESIA LEVEL; ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; CAT; DRUG EFFECT; DRUG POTENTIATION; ELECTROENCEPHALOGRAM; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032975111     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199903000-00030     Document Type: Article

References (28)

1. Aantaa R, Jaakola M-L, Kallio A, Kanto J. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology 1997;86:1055-60.
2. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
3. Devcic A, Schmeling WT, Kampine JP, Warltier DC. Oral dexmedetomidine preser\'es baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs. Anesthesiology 1994;81:419-30.
4. Correa-Sales C, Nacif-Coelho C, Reid K, Maze M. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat. J Pharmacol Exp Ther 1992;263:1046-9.
5. Correa-Sales C, Rabin EC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992;76:948-52.
6. Guo TZ, Jiang JY, Buttermann AE, Maze M. Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 1996;84:873-81.
7. Rampil IJ, Mason P, Singh H.. Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 1993,78:707-12.
8. Jackson C, Eisenach JC. Spinal administration of alpha2adrenergic agonists. Anesth Pharmacol Rev 1993;l:288-r96.
9. Sabbe MB, Penning JP, Ozaki GT, Yaksh TL. Spinal and systemic action of the alpha 2 receptor agonist dexmedetomidine in dogs: antinociception and carbon dioxide response. Anesthesiology 1994;80:1057-72.
10. Roizen MF, Horrigan RVV, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision: MAC BAR. Anesthesiology 1981;54:390-8.
11. Laubie M, Schmitt H, Drouillat M. Action of clonidine on the baroreceptor pathway and medullary sites mediating vagal bradycardia. Eur J Pharmacol 1976;38:293-303.
12. Reis DJ, Granata AR, Joh TH, et al. Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure. Hypertension 1984;6(5 Pt 2):7-15.
13. Schmeling WT, Farber NE. Anesthetic actions on cardiovascular control mechanisms in the central nervous system. Adv Pharmacol 1994,31:617-24.
14. Farber NE, Samso E, Staunton M, et al. Schmeling WT. Dexmedetomidine modulates cardiovascular responses to stimulation of central nervous system presser sites in cats anesthetized with halothane. Anesth Analg 1999;88:617-24.
15. Gustafsson LL, Ebling WF, Osaki E, Stanski DR. Quantitation of depth of thiopental anesthesia in the rat. Anesthesiology 1996; 84:415-27.
16. Rampil IJ, Laster MJ. No correlation between quantitative electroencephalographic measurements and movement response to noxious stimuli during isoflurane anesthesia in rats. Anesthesiology 1992;77:920-5.
17. Eger El II. Anesthetic uptake and action. Baltimore: Williams & Wilkins, 1974.
18. Schmeling WT, Farber NE. The effects of a2-adrenergic agonists on the cardiovascular system. Semin Cardiothorac Vase Anesth 1997;l:178-96.
19. 2-adrenoceptors. Anaesth Pharmacol Rev 1993;l:246-62.
20. Calaresu FR, Ciriello J, Caverson MM. Functional neuroanatomy of central pathways controlling the circulation. In: Guthrie GP Jr, Kotchen TA, eds. Hypertension and the brain. Mount Kisco, NY: Futura Publishing, 1984:3-21.
21. Ossipov MH, Gebhart GF. Absence of antinociceptive effect of alpha-2 agonists microinjected in the periaqueductal gray of the rat. Brain Res 1983;289:349-54.
22. Spaulding TC, Venafro JJ, Ma MG, Fielding S. The dissociation of the antinociceptive effect of clonidine from supraspinal structures. Neuropharmacology 1979;18:103-5.
23. Hirata K, Koyama N, Minami T. The effects of clonidine and tizanidine on responses of nociceptive neurons in nucleus ventralis posterolateralis of the cat thalamus. Anesth Analg 1995; 81:259-64.
24. Zbinden AM, Maggiorini M, Petersen-Felix S, et al. Anesthetic depth defined using multiple noxious stimuli during isoflurane/ oxygen anesthesia. I Motor reactions. Anesthesiology 1994;80: 253-60.
25. Unnerstall JR, Kuhar MJ. Mapping the alpha-adrenergic receptor in the central nervous system: a guide to structure and function. In: Stolk JM, U'Prichard DC, Fuxe K, eds. Epinephrine in the central nervous system. New York: Oxford University Press, 1988:45-59.
26. Farber NE, Poterack KA, Schmeling WT. Dexmedetomidine and halothane produce similar alterations in electroencephalographic and electromyographic activity in cats. Brain Res 1997; 774:131-41.
27. Bimar J, Bellville JW. Arousal reactions during anesthesia in man. Anesthesiology 1977;47:449-54.
28. Zbinden AM, Petersen-Felix S, Thomson DA. Anesthetic depth defined using multiple noxious stimuli during isoflurane/ oxygen anesthesia. II Hemodynamic responses. Anesthesiology 1994;80:261-7.